首页> 外文期刊>BMC Veterinary Research >Antitrypanosomal activity of aloin and its derivatives against Trypanosoma congolense field isolate
【24h】

Antitrypanosomal activity of aloin and its derivatives against Trypanosoma congolense field isolate

机译:芦荟素及其衍生物对锥虫锥虫的抗锥虫活性

获取原文
           

摘要

Background There is an urgent need for the development of new, cheap, safe and highly effective drugs against African trypanosomiasis that affects both man and livestock in sub-Saharan Africa including Ethiopia. In the present study the exudate of Aloe gilbertii , an endemic Aloe species of Ethiopia, aloin, aloe-emodin and rhein were tested for their in vitro and in vivo antitrypanosomal activities against Trypanosoma congolense field isolate. Aloin was prepared from the leaf exudate of A. gilbertii by acid catalyzed hydrolysis. Aloe-emodin was obtained by oxidative hydrolysis of aloin, while rhein was subsequently derived from aloe-emodin by oxidation. In vitro trypanocidal activity tests were conducted on parasites obtained from infected mice, while mice infected with T. congolense were used to evaluate in vivo antitrypanosomal activity of the test substances. Results Results of the study showed that all the test substances arrested parasites motility at effective concentration of 4.0 mg/ml within an incubation period ranging from 15 to 40 min. Moreover, the same concentration of the test substances caused loss of infectivity of the parasites to mice during 30 days observation period. Among the tested substances, rhein showed superior activity with minimum inhibitory concentration (MIC) of 0.4 mg/ml. No adverse reactions were observed when the test substances were administered at a dose of 2000 mg/kg. Rhein at doses of 200 and 400 mg/kg, and the exudate, aloin and aloe-emodin at a dose of 400 mg/kg reduced the level of parasitaemia significantly ( P Conclusion The results obtained in this investigation indicate that aloin and its derivatives particularly rhein have the potential to be used as a scaffold for the development of safe and cost effective antitrypanosomal drugs that can be useful in the continuing fight against African trypanosomiasis.
机译:背景技术迫切需要开发新的,廉价的,安全的和高效的抗非洲锥虫病的药物,这种药物可影响包括埃塞俄比亚在内的撒哈拉以南非洲的人和牲畜。在本研究中,测试了埃塞俄比亚特有芦荟种吉尔伯芦荟,芦荟素,芦荟大黄素和大黄酸的渗出液在体外和体内对锥虫锥虫分离株的抗锥虫活性。通过酸催化水解从吉尔伯特氏菌的叶子渗出液制备芦丁。芦荟大黄素通过芦荟的氧化水解而获得,而大黄酸随后通过氧化衍生自芦荟大黄素。在从感染小鼠获得的寄生虫上进行了体外锥虫杀灭活性测试,而用弓形虫感染的小鼠被用来评估受试物质的体内抗锥虫活性。结果研究结果表明,所有受试物质在15至40分钟的潜伏期内均能以4.0 mg / ml的有效浓度抑制寄生虫的蠕动。此外,在30天的观察期内,相同浓度的测试物质会导致寄生虫对小鼠的传染性丧失。在受试物质中,大黄酸显示出优异的活性,最低抑制浓度(MIC)为0.4 mg / ml。当以2000mg / kg的剂量施用测试物质时,未观察到不良反应。大黄酸的剂量为200和400 mg / kg,渗出液,芦荟素和芦荟大黄素的剂量为400 mg / kg可以显着降低寄生虫血症的水平(P结论结论:本研究获得的结果表明,芦荟素及其衍生物尤其大黄酸有潜力用作开发安全和具有成本效益的抗锥虫病药物的支架,这些药物可用于持续抗击非洲锥虫病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号